<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02788396</url>
  </required_header>
  <id_info>
    <org_study_id>B853</org_study_id>
    <nct_id>NCT02788396</nct_id>
  </id_info>
  <brief_title>The Impact of Post Stenting Balloon Dilatation on Coronary Microcirculation in STEMI Patients Undergoing PPCI</brief_title>
  <acronym>POSTDILSTEMI</acronym>
  <official_title>The Impact of Post Stenting Balloon Dilatation on Coronary Microcirculation in ST Segment Elevation Myocardial Infarction (STEMI) Patients Undergoing Primary Percutaneous Coronary Intervention (PPCI)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mid and South Essex NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Anglia Ruskin University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mid and South Essex NHS Foundation Trust</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to assess the impact of NC balloon post-dilatation on coronary&#xD;
      microcirculation in patients with ST segment elevation myocardial infarction (STEMI)&#xD;
      undergoing primary percutaneous coronary intervention (PPCI).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Suboptimal stent deployment can lead to future stent failure. Thus, optimising stent&#xD;
      deployment with non-compliant balloons (NC balloon) post dilatation (PD) at high pressures is&#xD;
      an established strategy. In the context of ST segment elevation myocardial infarction&#xD;
      (STEMI), PD has been correlated anecdotally with the no reflow phenomenon.&#xD;
&#xD;
      This study aims to determine the impact of stent post-dilation (PD) with NC balloons at high&#xD;
      pressures on coronary microcirculation during PPCI by measuring the index of microcirculatory&#xD;
      resistance (IMR) pre and post stent post-dilatation. Pre and post PD, an optical coherence&#xD;
      tomography (OCT) study will be performed to assess stent deployment and identify parameters&#xD;
      that predict the changes in IMR.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 1, 2016</start_date>
  <completion_date type="Actual">May 31, 2018</completion_date>
  <primary_completion_date type="Actual">May 31, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Delta index of microcirculatory resistance (dIMR)</measure>
    <time_frame>index procedure</time_frame>
    <description>Delta index of microcirculatory resistance (dIMR) [dΙΜΡ = IMR post post-dilation (post IMR) - IMR pre post-dilation (pre IMR)]</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Minimum stent area (MSA)</measure>
    <time_frame>index procedure</time_frame>
    <description>Pre and post dilatation minimum stent area</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent expansion</measure>
    <time_frame>index procedure</time_frame>
    <description>Pre and post dilatation stent expansion; defined as the minimum stent area divided by the average of proximal and distal reference lumen areas x 100</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent mal-apposition</measure>
    <time_frame>index procedure</time_frame>
    <description>Stent mal-apposition pre and post dilatation; defined as a distance between the strut's luminal edge and luminal vessel wall of greater &gt;200 μm for a length &gt;600 μm (appreciable in &gt;3 contiguous frames at a pull-back speed of 20 mm/sec</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intra-stent plaque protrusion and thrombus</measure>
    <time_frame>index procedure</time_frame>
    <description>Pre and post dilatation intra-stent plaque protrusion and thrombus; defined as a mass attached to the luminal surface or floating within the lumen at least 200 μm beyond the luminal edge of a strut</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent edge dissections</measure>
    <time_frame>index procedure</time_frame>
    <description>Edge dissections pre and post dilatation, further defined as major and minor [major dissections defined as the ones with a dissection flap width greater or equal to 200 μm)</description>
  </secondary_outcome>
  <enrollment type="Actual">30</enrollment>
  <condition>ST-elevation Myocardial Infarction (STEMI)</condition>
  <eligibility>
    <study_pop>
      <textblock>
        STEMI patients undergoing PPCI&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria&#xD;
&#xD;
          -  &gt;18 years of age&#xD;
&#xD;
          -  Acute symptoms onset with duration &gt; 20 minutes&#xD;
&#xD;
          -  ST-segment elevation ≥ 0.1 mV in ≥ 2 contiguous leads, signs of a true posterior&#xD;
             infarction or documented newly developed left bundle branch block&#xD;
&#xD;
          -  Infarct related artery with a diameter above 2.5 mm&#xD;
&#xD;
          -  Operator's intention to proceed to stent deployment (i.e. not refer for CABG or defer&#xD;
             PCI)&#xD;
&#xD;
        Exclusion Criteria&#xD;
&#xD;
          -  &lt; 18 year of age&#xD;
&#xD;
          -  Symptoms duration &gt; 12 hours&#xD;
&#xD;
          -  Unable to give informed consent&#xD;
&#xD;
          -  Previous bypass graft surgery&#xD;
&#xD;
          -  Previous myocardial infarction&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Known severe chronic kidney disease (creatinine clearance ≤30 mL/min), unless the&#xD;
             patient is on dialysis&#xD;
&#xD;
          -  Unable to receive antiplatelets or anticoagulation (i.e. coagulation disorders,&#xD;
             bleeding etc.)&#xD;
&#xD;
          -  Haemodynamic instability&#xD;
&#xD;
          -  Severe LMS disease&#xD;
&#xD;
          -  Culprit vessel diameter &lt; 2.5 mm&#xD;
&#xD;
          -  Contraindications to adenosine&#xD;
&#xD;
          -  Any study lesion characteristic resulting in the expected inability to deliver OCT&#xD;
             catheter to the lesion pre and post PD (e.g. moderate or severe vessel calcification&#xD;
             or tortuosity)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John R Davies, MD PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Mid and South Essex NHS Foundation Trust</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Essex Cardiothoracic Centre</name>
      <address>
        <city>Basildon</city>
        <state>Essex</state>
        <zip>SS16 5NL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>May 27, 2016</study_first_submitted>
  <study_first_submitted_qc>May 27, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 2, 2016</study_first_posted>
  <last_update_submitted>August 31, 2021</last_update_submitted>
  <last_update_submitted_qc>August 31, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>STEMI</keyword>
  <keyword>PPCI</keyword>
  <keyword>post-dilatation</keyword>
  <keyword>coronary microcirculation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>ST Elevation Myocardial Infarction</mesh_term>
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Dilatation, Pathologic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

